Mineralys Therapeutics, Inc. MLYS Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCash.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s restricted cash?
- Mineralys Therapeutics, Inc. (MLYS) reported restricted cash of $0 in Q1 2026.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s restricted cash?
- Over 4 years (2021 to 2025), Mineralys Therapeutics, Inc.'s restricted cash has grown at a -100.0% compound annual growth rate (CAGR), from $50K to $0.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.